"The U.S. Food and Drug Administration today approved Sivextro (tedizolid phosphate), a new antibacterial drug, to treat adults with skin infections.
Sivextro is approved to treat patients with acute bacterial skin and skin structure infecti"...
During clinical trials with Naftin® (naftifine) Gel, 1%, the incidence of adverse reactions was as follows: burning/stinging (5.0%), itching (1.0%), erythema (0.5%), rash (0.5%), skin tenderness (0.5%).
Read the Naftin Gel (naftifine) Side Effects Center for a complete guide to possible side effects
No information provided.
Last reviewed on RxList: 6/11/2008
This monograph has been modified to include the generic and brand name in many instances.
Additional Naftin Gel Information
Report Problems to the Food and Drug Administration
Find out what women really need.